- Home
- FDMT vs GLO Comparison
FDMT vs GLO Comparison
Compare FDMT & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- GLO
- Stock Information
- Founded
- FDMT 2013
- GLO 2006
- Country
- FDMT United States
- GLO United States
- Employees
- FDMT N/A
- GLO N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- GLO Finance/Investors Services
- Sector
- FDMT Health Care
- GLO Finance
- Exchange
- FDMT Nasdaq
- GLO Nasdaq
- Market Cap
- FDMT 268.6M
- GLO 220.0M
- IPO Year
- FDMT 2020
- GLO N/A
- Fundamental
- Price
- FDMT $4.64
- GLO $5.23
- Analyst Decision
- FDMT Buy
- GLO
- Analyst Count
- FDMT 10
- GLO 0
- Target Price
- FDMT $36.33
- GLO N/A
- AVG Volume (30 Days)
- FDMT 957.1K
- GLO 170.5K
- Earning Date
- FDMT 03-03-2025
- GLO 01-01-0001
- Dividend Yield
- FDMT N/A
- GLO 11.38%
- EPS Growth
- FDMT N/A
- GLO N/A
- EPS
- FDMT N/A
- GLO N/A
- Revenue
- FDMT $17,000.00
- GLO N/A
- Revenue This Year
- FDMT N/A
- GLO N/A
- Revenue Next Year
- FDMT $159.36
- GLO N/A
- P/E Ratio
- FDMT N/A
- GLO N/A
- Revenue Growth
- FDMT N/A
- GLO N/A
- 52 Week Low
- FDMT $4.41
- GLO $4.08
- 52 Week High
- FDMT $36.25
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- FDMT 40.01
- GLO 43.62
- Support Level
- FDMT $4.41
- GLO $5.23
- Resistance Level
- FDMT $5.42
- GLO $5.32
- Average True Range (ATR)
- FDMT 0.48
- GLO 0.05
- MACD
- FDMT -0.05
- GLO -0.01
- Stochastic Oscillator
- FDMT 9.38
- GLO 31.25
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.